The new chief executive officer of Ingham Institute for Applied Medical Research, Stephen Thompson, says he wants to lead a culture of innovation.
“I am impressed by the alignment of purpose and well-defined strategy focused on improving the health and wellbeing of our diverse and unique community in South Western Sydney,” he said.
“I look forward to developing my previous experience in the healthcare ecosystem, into the service delivery of our Ingham Institute research.
“This is only possible through our relationships with the Local Health District, our university partners, government and of course a world-class team.’’
Mr Thompson commenced with the Institute on May 22 in preparation for the retirement of long-standing CEO Darryl Harkness on June 30.
A highly experienced board-level executive leader with a strong track record in leading multinational organisations, Mr Thompson has a passion for leading and developing teams that consistently deliver outstanding results.
“As Darryl Harkness prepares for his retirement, we are fortunate to have a solid transition period to introduce Stephen Thompson as CEO of the Ingham Institute for Applied Medical Research,’’ says board chairman Terry Goldacre.
“We are excited to welcome Stephen at this pivotal juncture as the institute commences enacting our 2023-2026 strategic plan.
“Stephen brings a wealth of healthcare and commercial experience, fully aligned to our vision, mission and strategy.
“His leadership will hasten the delivery and impact of our mission to combine local purpose, national significance, and global impact, by making and applying discoveries that translate to measurable improvements in health and healthcare, and radically improve the quality of life for all.
“Stephen is looking forward to bringing his broad leadership experience from a variety of industries to the Ingham Institute to help continue our vision of inspiring health and transforming care.’’
